Funding is the lifeblood of innovation. In the current economic climate, funding sources have become more difficult to obtain. This session will cover the current environment for supporting innovation in the US, recent trends, and identify strategies and sources for funding at the device, diagnostic and drug interface.

Learning Objectives:
Discuss how investors evaluate funding opportunities at the device, diagnostic and drug interface
Identify the different sources of funding and how to bridge the gap
Define approaches to obtain funding in emerging areas Describe connecting capital with innovators.